Epidermolysis Bullosa Simplex Ogna Revisited  by Kiritsi, Dimitra et al.
Ikoma A, Fartasch M, Heyer G et al. (2004) Painful
stimuli evoke itch in patients with chronic
pruritus: Central sensitization for itch. Neu-
rology 62:212–7
Imamachi N, Park GH, Lee H et al. (2009) TRPV1-
expressing primary afferents generate beha-
vioral responses to pruritogens via multiple
mechanisms. Proc Natl Acad Sci USA
106:11330–5
Johanek LM, Meyer RA, Hartke T et al. (2007)
Psychophysical and physiological evi-
dence for parallel afferent pathways mediat-
ing the sensation of itch. J Neurosci 27:
7490–7
Namer B, Carr R, Johanek LM et al. (2008)
Separate peripheral pathways for pruritus in
man. J Neurophysiol 100:2062–9
Obreja O, Kluschina O, Mayer A et al. (2011)
NGF enhances electrically induced pain,
but not axon reflex sweating. Pain 152:
1856–63
Ringkamp M, Schepers RJ, Shimada SG et al.
(2011) A role for nociceptive, myelinated
nerve fibers in itch sensation. J Neurosci
31:14841–9
Rukwied R, Mayer A, Kluschina O et al. (2010)
NGF induces non-inflammatory localized
and lasting mechanical and thermal hyper-
sensitivity in human skin. Pain 148:407–13
Sikand P, Shimada SG, Green BG et al. (2009)
Similar itch and nociceptive sensations
evoked by punctate cutaneous application
of capsaicin, histamine and cowhage. Pain
144:66–75
Smith ES, Blass GR, Lewin GR et al. (2010)
Absence of histamine-induced itch in the
African naked mole-rat and ‘‘rescue’’ by
Substance P. Mol Pain 6:29
Takano N, Sakurai T, Kurachi M (2005) Effects of
anti-nerve growth factor antibody on symp-
toms in the NC/Nga mouse, an atopic
dermatitis model. J Pharmacol Sci 99:277–86
Tominaga M, Tengara S, Kamo A et al. (2009)
Psoralen-ultraviolet A therapy alters epider-
mal Sema3A and NGF levels and modulates
epidermal innervation in atopic dermatitis.
J Dermatol Sci 55:40–6
Yamaguchi J, Aihara M, Kobayashi Y et al. (2009)
Quantitative analysis of nerve growth
factor (NGF) in the atopic dermatitis and
psoriasis horny layer and effect of treatment
on NGF in atopic dermatitis. J Dermatol Sci
53:48–54
Yamaura K, Doi R, Suwa E et al. (2011) A novel
animal model of pruritus induced by succes-
sive application of glucocorticoid to mouse
skin. J Toxicol Sci 36:395–401
Epidermolysis Bullosa Simplex Ogna Revisited
Journal of Investigative Dermatology (2013) 133, 270–273; doi:10.1038/jid.2012.248; published online 2 August 2012
TO THE EDITOR
Epidermolysis bullosa simplex (EBS),
basal type, is a heterogeneous group
of genetic mechanobullous disorders
characterized by cytolysis of epidermal
basal keratinocytes. In about 75% of the
cases, it is associated with dominantly
inherited mutations in the genes for
keratin 5 (KRT5) or 14 (KRT14) (Bolling
et al., 2010). In rare cases, mutations
in other genes, including PLEC
(NM_000445.3) encoding plectin, DST
(NM_001723.5) encoding BPAG1e, the
isoform 3 of dystonin (UniProt identi-
fier: Q03001-3) (Groves et al., 2010), or
COL17A1 encoding collagen XVII have
been associated with tissue separation
within the basal epidermis (Fine et al.,
2008). Plectin mutations result in dis-
tinct phenotypes, including EBS with
muscular dystrophy, EBS with pyloric
atresia, and EBS-Ogna (Rezniczek
et al., 2010). EBS with muscular dystro-
phy is characterized by congenital
blistering and progressive muscular
weakness, whereas EBS with pyloric
atresia comprises neonatal blistering,
pyloric atresia, and often early demise
(Rezniczek et al., 2010). In contrast to
these severe recessive subtypes, the
dominant EBS-Ogna has a mild course.
It is caused by the specific PLEC
mutation p.Arg2000Trp, and has been
reported in only two families so far
(Koss-Harnes et al., 2002).
Here we report three unrelated
families with EBS-Ogna and describe
eight affected individuals carrying the
PLEC mutation p.Arg2000Trp. All had
mild skin fragility that had been initially
misdiagnosed or remained unrecog-
nized.
Diagnostic skin biopsies of the index
patients were subjected to indirect
immunofluorescence (IIF) staining using
a panel of antibodies to components of
the dermal–epidermal junction (Herz
et al., 2006), including the domain-
specific plectin antibodies: against the
rod domain, 5B3 (Foisner et al., 1994)
(a kind gift from Dr G Wiche, Vienna,
Austria) and 10F6 (Santa Cruz Biotech-
nology, Heidelberg, Germany),
and against the C-terminus, 31/Plectin
(directed against amino acids
3,062–3,184, BD Biosciences, Heidel-
berg, Germany) and GP21 (directed
against amino acids 4,367–4,684, Pro-
gen Biotechnik, Heidelberg, Germany).
The project was approved by the ethics
committee of the University of Freiburg.
For mutation analyses, EDTA–blood
was obtained from patients and family
members following written informed
consent in adherence to the Declara-
tion of Helsinki principles. The primers
for amplification of PLEC exons 31
and 32, and KRT5/KRT14, have been
described previously (McLean et al.,
1996; Arin et al., 2010), or designed
with primer 3.
The index patient of family A was
reported to be the only affected mem-
ber of the family (Figure 1a). He
had trauma-induced acral blisters and
erosions since the age of 3 years. With
increasing age, blistering diminished
and erosions predominated. Other
features encompassed posttraumatic
violaceous macules, hypopigmented
macules, especially evident on the
back, mild focal palmoplantar kerato-
derma, and pitting of the teeth (Figure
1b and c). IIF with the antibodies 5B3
and 10F6 indicated intraepidermal
microblisters and reduced staining
for plectin. PLEC mutation analysis
disclosed the heterozygous mutation
p.Arg2000Trp not only in the index
case but also in his father and two
siblings. Careful clinical examination
revealed mild skin fragility in all ofAbbreviations: EBS, epidermolysis bullosa simplex; IIF, indirect immunofluorescence; PLEC, plectin gene
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them. Mechanically induced erosions
on the lower legs and arms (Figure 1c,
Supplementary Table S1 online) had
been considered harmless by them.
These findings encouraged us to
revisit 40 cases with clinically sus-
pected EBS, in which KRT5 and
KRT14 mutations had been excluded.
During this process, we identified
two further families with EBS-Ogna,
designated as B and C. When we
first performed IIF in the index cases
of these two families, only the antibody
31/plectin was available and no change
in the staining pattern was noted.
Therefore, in both cases, a plectin
anomaly was initially not suspected.
In family B, several individuals were
affected (Figure 1d), but clinical data
and DNA were only available from the
34-year-old index case. Starting from
the age of 18 years, he has had trauma-
induced blisters restricted to hands and
feet (Figure 1e).
In the index patient of family C,
C.II.2, onset of posttraumatic erosions
and blistering started at the age of 8
years. Clinical findings included small
erosions on the extremities, which
healed with violaceous macules (Figure
1f), and spotty and linear hypopigmen-
ted macules on the trunk. Mutation
analysis disclosed the heterozygous
PLEC mutation p.Arg2000Trp in the
index case, his mother, and his brother.
Latter two had acral blisters and
erosions since their childhood, with
predominance of erosions with age
(Supplementary Table S1 online).
As only few data on EBS-Ogna exist,
we evaluated skin morphology with IIF
stainings of plectin and other compo-
nents of the dermal–epidermal junction
(Figure 2a) in the index patient of
family A. Hematoxylin and eosin stain-
ing of cryosections revealed (micro)
blisters at the dermal–epidermal junc-
tion (Figure 2b). The signal obtained
with the plectin antibodies 5B3 and
10F6, which recognize the rod domain,
was reduced, as described before (Koss-
Harnes et al., 1997). In contrast, with
the C-terminus-specific 31/Plectin and
GP21 antibodies the signal was pre-
served and comparable to the control
skin (Figure 2c and d, Supplementary
Figure S1 online). The hemidesmoso-
mal components BPAG1e, collagen
XVII, and the b4 integrin subunit
showed a reduced and interrupted IIF
staining with small, ‘‘cell-sized’’ gaps
(Figure 2e and f). Other markers of
the dermal–epidermal junction zone
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Figure 1. Pedigrees and clinical presentation of the patients with epidermolysis bullosa simplex (EBS)-Ogna. (a) Pedigree of family A. (b) The 11-year-old
index patient A.III.6 presented with serous (open arrow) and hemorrhagic blisters (white arrow) on the foot, violaceous macules on the lower legs after
healing of erosions and linear, as well as spotty hypopigmented macules on the back. (c) The lower legs from patient A.III.6, 45-year-old patient A.II.4,
21-year-old patient A.III.4, and 27-year-old patient A.III.1 show erosions. In a detailed representation of A.III.1 patient’s lower leg, the violaceous
macules, which occur after healing of blisters and erosions, are pointed out by black arrows. (d) Pedigree of family B. (e) The 34-year-old index patient B.III.1
has serous (open arrow) and hemorrhagic blisters (white arrow) on the sole. (f) The 14-year-old index patient of family C, C.II.2, presented with erosions
on lower legs.
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Figure 2. Morphological analysis of epidermolysis bullosa simplex (EBS)-Ogna skin. (a) Schematic representation of plectin and hemidesmosomes in the skin.
The N-terminus of plectin contains an actin-binding domain and a plakin domain, which harbors binding sites for the b4 integrin subunit and collagen XVII.
The C-terminus consists of 6 plakin repeat domains and acts as a linking side for keratin 5 and 14. The central rod domain has the role of a structural spacer
between the N- and C-termini. The mutation p.Arg2000Trp is depicted with a red arrow. (b) In hematoxylin and eosin staining of the skin of patient A.III.6
(micro) blisters are indicated by black stars. (c–h) Indirect immunofluorescence staining of plectin and other components of the dermal–epidermal junction.
In the skin of the patient, (c) the signal for the rod domain–specific plectin antibody 5B3 is reduced, whereas (d) the signal is positive and comparable
to the control with the C-terminus-specific plectin antibody 31/Plectin. (c, d) The signal for the integrin a6 subunit remained unchanged. (e, f) BPAG1e, collagen
XVII, and the b4 integrin subunit show an interrupted staining with small, ‘‘cell-sized’’ gaps (white arrows) in the patient’s skin. Keratin 5/6 and laminin 332 stain
similar to control skin. Bar¼20 mm.
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showed no abnormalities (Figure 2g
and h). Comparable findings were
reported in the mouse model for EBS-
Ogna, which had no overt skin lesions,
but microblisters on microscopic exam-
ination (Walko et al., 2011).
Plectin is widely expressed in the
mammalian tissues and evidence has
been provided for the occurrence of
tissue-specific isoforms. Both plectin 1a
and 1c are expressed in the skin, but
only plectin 1a is specifically asso-
ciated with hemidesmosomal structures
in basal keratinocytes (Andra et al.,
2003; Rezniczek et al., 2010). Plectin,
together with the b4 integrin subunit, is
indispensable for hemidesmosome as-
sembly, and both are required for
correct incorporation of BPAG1e and
collagen XVII into the hemidesmo-
somes, as they provide stability to these
structures (Koster et al., 2003, 2004).
The mutation p.Arg2000Trp is located
in the rod domain of plectin, and in the
EBS-Ogna mouse model it was shown
to disrupt the coiled-coil arrangement
of the rod domain, making solely the
plectin 1a isoform susceptible to pro-
teolytic degradation (Walko et al.,
2011). As the rod domain is function-
ally involved in the dimerization of
plectin, the mutation may also cause
conformational changes in the dimer,
thus hampering interactions.
The clinical findings in the patients
of this study are very similar to the
initial description of EBS-Ogna (Gedde-
Dahl, 1971). However, the diagnosis
can easily be overseen. Mild skin
fragility manifesting predominantly
with erosions, which heal with violac-
eous macules, seem to be the
main features that may distinguish
this rare subtype from the frequent
keratin-associated EBS. Reduction of
the staining with 5B3 and 10F6, rod-
domain-specific antibodies, combined
with reduced and interrupted staining
of other hemidesmosomal-binding
partners, strongly supports the diagno-
sis, which is confirmed by mutation
analysis. In this study, analysis of
common PLEC polymorphisms sug-
gested that all affected individuals
of German ancestry share the same
haplotype (Supplementary Table S2
online).
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